Ulrike Harjes - Publications
Affiliations: | 2010-2015 | University of Oxford, Oxford, United Kingdom |
Year | Citation | Score | |||
---|---|---|---|---|---|
2020 | Bridges E, Sheldon H, Kleibeuker E, Ramberger E, Zois C, Barnard A, Harjes U, Li JL, Masiero M, MacLaren R, Harris A. RHOQ is induced by DLL4 and regulates angiogenesis by determining the intracellular route of the Notch intracellular domain. Angiogenesis. PMID 32506201 DOI: 10.1007/S10456-020-09726-W | 0.41 | |||
2019 | Lord SR, Collins JM, Cheng WC, Haider S, Wigfield S, Gaude E, Fielding BA, Pinnick KE, Harjes U, Segaran A, Jha P, Hoefler G, Pollak MN, Thompson AM, Roy PG, et al. Transcriptomic analysis of human primary breast cancer identifies fatty acid oxidation as a target for metformin. British Journal of Cancer. PMID 31819193 DOI: 10.1038/s41416-019-0665-5 | 0.455 | |||
2017 | Treps L, Conradi LC, Harjes U, Carmeliet P. Manipulating Angiogenesis by Targeting Endothelial Metabolism: Hitting the Engine Rather than the Drivers-A New Perspective? Pharmacological Reviews. 68: 872-87. PMID 27363442 DOI: 10.1124/pr.116.012492 | 0.328 | |||
2015 | Harjes U, Kalucka J, Carmeliet P. Targeting fatty acid metabolism in cancer and endothelial cells. Critical Reviews in Oncology/Hematology. 97: 15-21. PMID 26558689 DOI: 10.1016/j.critrevonc.2015.10.011 | 0.369 | |||
2014 | Harjes U, Bridges E, McIntyre A, Fielding BA, Harris AL. Fatty acid-binding protein 4, a point of convergence for angiogenic and metabolic signaling pathways in endothelial cells. The Journal of Biological Chemistry. 289: 23168-76. PMID 24939870 DOI: 10.1074/jbc.M114.576512 | 0.539 | |||
Show low-probability matches. |